共 48 条
- [42] Effects of luseogliflozin, a sodium-glucose co-transporter 2 inhibitor, on 24-h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, crossover study DIABETES OBESITY & METABOLISM, 2015, 17 (08) : 800 - 804
- [44] Predictors of Poor Glycemic Control and Increased Glucose Variability Among Admitted Moderate to Critical COVID-19 Patients with Type 2 Diabetes Mellitus: A Single Center Cross-sectional Study JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2023, 38 (02): : 57 - 64
- [45] Serum Levels of Anticyclic Citrullinated Peptide Antibodies, Interleukin-6, Tumor Necrosis Factor-α, and C-Reactive Protein Are Associated with Increased Carotid Intima-Media Thickness: A Cross-Sectional Analysis of a Cohort of Rheumatoid Arthritis Patients without Cardiovascular Risk Factors BIOMED RESEARCH INTERNATIONAL, 2015, 2015
- [47] Comparison of glucose variability assessed by a continuous glucose-monitoring system in patients with type 2 diabetes mellitus switched from NPH insulin to insulin glargine: The COBIN2 studyVergleich der mit einem kontinuierlichen Glukose Monitoring System gemessenen Blutzucker Variabilität bei Patienten mit Typ 2 Diabetes mellitus, die von NPH Insulin auf Insulin Glargin umgestellt wurden – Die COBIN2 Studie Wiener klinische Wochenschrift, 2014, 126 : 228 - 237
- [48] Which is better, high-dose metformin monotherapy or low-dose metformin/linagliptin combination therapy, in improving glycemic variability in type 2 diabetes patients with insufficient glycemic control despite low-dose metformin monotherapy? A randomized, cross-over, continuous glucose monitoring-based pilot study JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (03) : 714 - 722